(2 years, 7 months ago)
Westminster HallWestminster Hall is an alternative Chamber for MPs to hold debates, named after the adjoining Westminster Hall.
Each debate is chaired by an MP from the Panel of Chairs, rather than the Speaker or Deputy Speaker. A Government Minister will give the final speech, and no votes may be called on the debate topic.
This information is provided by Parallel Parliament and does not comprise part of the offical record
The hon. Lady is demonstrating the need for a railway system that is not fragmented, and highlighting the importance of the rail industry, not just for commuters and travel to work, but for the tourism sector and leisure.
Private businesses have always played a big role on the railway, originally as its creators, then as providers of passenger and freight serves, and suppliers and partners to Network Rail. Privatisation has been a success story for the rail network, with passenger numbers doubling in the 25 years before the pandemic, and passengers travelling more safely. [Interruption.] Some hon. Members might not like that, but numbers have doubled in 25 years. The private sector has invested billions into new, modern trains and the upgrading of stations.
Our reforms are about simplification—
It would be helpful to remind this debate of what has happened in our railways over the past few years. After decades of decline, we reached the point where we had only 760 million passenger journeys per year. The situation transformed, under privatisation, to 1.8 billion passenger journeys a year. I think the Minister should continue her history lesson to the Opposition Members, who really haven’t got a clue.
I am grateful to my hon. Friend for the intervention. Let me continue, because he does make some very important points on the private sector. GBR will harness the very best of the private sector—innovation, an unrelenting focus on quality, and outstanding customer service—and fuse it with a single guiding mind, empowered to drive benefits and efficiencies across the system as a whole.
I will quickly touch on some of the points raised by hon. Members. A number spoke of reform; I want to be absolutely clear that we are committed to workforce reform, which will make the railways financially and operationally sustainable for the future, to deliver in the ways that passengers want, and provide greater opportunities and more flexible roles for employees.
We talked about GBR; we also have the GBR transition team in place. While transformation on this scale cannot happen overnight, the Government and the sector are committed to ensuring that benefits for passengers and freight customers are brought forward as quickly as possible. Since our plan for rail, we have set up the GBR transition team, fulfilling the plan for rail’s commitment to start interim arrangements immediately.
The hon. Member for York Central referenced her bid for York to be the GBR HQ, as did others—my hon. Friends the Members for Thirsk and Malton (Kevin Hollinrake), for York Outer (Julian Sturdy) and for Harrogate and Knaresborough (Andrew Jones). GBRTT is currently overseeing the competition to select the national HQ for GBR, which is to be based outside of London, ensuring that skilled jobs, investment and economic benefits are delivered nationwide and in line with this Government’s historic commitment to levelling up across the nation.
I am pleased to say that we have received an amazing 42 applications—an incredibly positive response to the recent expression of interest phase. Obviously, there was one for York, and six others were mentioned by the hon. Member for Paisley and Renfrewshire North (Gavin Newlands). I am conscious of time, and I know that there have been other debates on GBR’s possible HQ locations, but I do commend the hon. Member for York Central for her tireless advocacy of York in the past.
I want to quickly touch on other points in the time that I have. On RNEP, please be patient; we will be coming forward with that in due course. There were very specific requests from the hon. Member for Ellesmere Port and Neston (Justin Madders) around services, new franchising, and a request for a meeting. I am happy to pick that up after the debate.
Various points were raised around accessibility and tactiles by a number of colleagues. That is something that I feel is very important, and we are absolutely committed to increasing the tactiles to 100%, and Network Rail has received an initial £10 million to install tactiles.
(4 years, 4 months ago)
Commons ChamberThat is a really important point. The Prime Minister has made it clear that equitable access is an integral part of the UK’s approach to vaccine development and distribution. Only last weekend, he emphasised how all the world’s leaders have a moral duty to ensure that covid-19 vaccines are truly available to all. That is why the UK has contributed more than £313 million of UK aid to CEPI, the COVID-19 Therapeutics Accelerator, the Access to COVID-19 Tools (ACT) Accelerator, and the Foundation for Innovative New Diagnostics. We have also committed £1.65 billion to Gavi over five years to strengthen immunisation for vaccine preventable disease in vulnerable countries.
Around the world, there are more than 100 programmes to develop a coronavirus vaccine. Can my hon. Friend confirm that our global diplomatic presence is assisting UK companies and universities to participate in those programmes, basically by using their local networks to highlight the significant expertise that the UK can contribute, but also vice versa to identify where those contacts can contribute to UK-based programmes, because this is truly a global effort?
Yes, our overseas network is working actively around the globe, particularly through our world-leading science and innovation network. The Vaccine Taskforce is also ensuring that work being done to find a vaccine in the UK complements and supports global efforts, including by providing industry and research institutions with resources and support. We welcome the announcement on 4 June of the innovative collaborations between AstraZeneca, CEPI, Gavi and the Serum Institute of India to support the production of 1.3 billion doses for global access to a potential covid-19 vaccine.